ANTIBODY-DRUG CONJUGATES
Clinical trials for ANTIBODY-DRUG CONJUGATES explained in plain language.
Never miss a new study
Get alerted when new ANTIBODY-DRUG CONJUGATES trials appear
Sign up with your email to follow new studies for ANTIBODY-DRUG CONJUGATES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat cancers: experimental drug targets HER2-positive tumors
Disease control Recruiting nowThis study tests a drug called trastuzumab rezetecan in people with advanced solid tumors that are HER2-positive and have not responded to standard therapies. About 90 participants with three types of cancer (extramammary Paget's disease, rare solid tumors, or urothelial carcinom…
Matched conditions: ANTIBODY-DRUG CONJUGATES
Phase: PHASE2 • Sponsor: Sheng Zhang • Aim: Disease control
Last updated May 17, 2026 01:49 UTC
-
Socks may shield cancer patients from nerve pain during chemotherapy
Prevention Recruiting nowThis study tests whether wearing a compression stocking on one foot during antibody-drug conjugate (ADC) infusions can prevent nerve damage (peripheral neuropathy). About 58 adults with advanced cancers like bladder cancer will take part. Each person will wear a stocking on their…
Matched conditions: ANTIBODY-DRUG CONJUGATES
Phase: NA • Sponsor: Sheng Zhang • Aim: Prevention
Last updated May 12, 2026 13:41 UTC